Ibrutinib Related Products 
![Picture of Ibrutinib Addition Adduct with (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)](https://www.venkatasailifesciences.com/images/thumbs/0043971_ibrutinib-addition-adduct-with-r-1-3-4-amino-3-4-phenoxyphenyl-1h-pyrazolo34-dpyrimidin-1-ylpiperidi_350.png "Show details for Ibrutinib Addition Adduct with (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)")
![Picture of Namino-{3-[(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl]-propionyl} Ibrutinib](https://www.venkatasailifesciences.com/images/thumbs/0056458_namino-3-r-1-3-4-amino-3-4-phenoxyphenyl-1h-pyrazolo34-dpyrimidin-1-ylpiperidin-1-yl-propionyl-ibrut_350.png "Show details for Namino-{3-[(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl]-propionyl} Ibrutinib")
Venkatasai is a leading innovator in the field of pharmaceutical reference standards, offering high-quality Reference Standards of Abacavir, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamines (N-NO products). Our Abacavir impurity reference standards play a vital role in pharmaceutical research, supporting product development, ANDA and DMF filings, quality control (QC), method validation, and stability studies. They are also instrumental in identifying unknown impurities and evaluating genotoxic potential. All Abacavir-related products are thoroughly characterized and supplied with comprehensive Certificates of Analysis (COA) and analytical data that comply with regulatory standards. EP/USP traceable standards can also be provided upon request. Furthermore, all supplied products undergo periodic re-testing to ensure continued quality and reliability.
(R)-N-Desacryloyl N-Propionyl Ibrutinib
CAT No: VS-I002007
CAS No: 1839099-22-7
Mol.F.: C25H26N6O2
Mol.Wt.: 442.5
Status: Custom Synthesis
Dihydrodiol Ibrutinib
CAT No: VS-I002046
CAS No: 1226872-27-0
Mol.F.: C25H26N6O4
Mol.Wt.: 474.51
Status: Custom Synthesis
Ibrutinib
CAT No: VS-I002000
CAS No: 936563-96-1
Mol.F.: C25H24N6O2
Mol.Wt.: 440.5
Status: Custom Synthesis
Ibrutinib - Acetyl Impurity
CAT No: VS-I002026
CAS No: 1288338-95-3
Mol.F.: C24H24N6O2
Mol.Wt.: 428.5
Status: Custom Synthesis
Ibrutinib - Di acrylate impurity
CAT No: VS-I002048
CAS No: NA
Mol.F.: C28H26N6O3
Mol.Wt.: 494.6
Status: Custom Synthesis
Ibrutinib - impurity A
CAT No: VS-I002047
CAS No: 1288338-97-5
Mol.F.: C47H46N12O3
Mol.Wt.: 827.0
Status: Custom Synthesis
Ibrutinib Addition Adduct with (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)
CAT No: VS-I002012
CAS No: N/A
Mol.F.: C47H45N11O3
Mol.Wt.: 827
Status: Custom Synthesis
Ibrutinib Amino piperidine Impurity
CAT No: VS-I002032
CAS No: 1701403-10-2
Mol.F.: C22H24Cl2N6O
Mol.Wt.: 459.37
Status: Custom Synthesis
Ibrutinib Des acrylate dimer
CAT No: VS-I002027
CAS No: 1987905-93-0
Mol.F.: C47H46N12O3
Mol.Wt.: 827
Status: In Stock
Ibrutinib Diamide Impurity
CAT No: VS-I002019
CAS No: 1917333-91-5
Mol.F.: C28H26N6O3
Mol.Wt.: 494.6
Status: Custom Synthesis
Ibrutinib Dihydrodiol R-Isomer
CAT No: VS-I002008
CAS No: 1654820-87-7
Mol.F.: C25H26N6O4
Mol.Wt.: 474.5
Status: Custom Synthesis
Ibrutinib Dimer
CAT No: VS-I002014
CAS No: 2031255-23-7
Mol.F.: C50H48N12O4
Mol.Wt.: 881
Status: In Stock
Ibrutinib Dimer Impurity 2
CAT No: VS-I002029
CAS No: 2417548-76-4
Mol.F.: C50H48N12O4
Mol.Wt.: 881
Status: Custom Synthesis
Ibrutinib Dimer Impurity-II
CAT No: VS-I002017
CAS No: 2540665-98-1
Mol.F.: C50H48N12O4
Mol.Wt.: 881
Status: Custom Synthesis
Ibrutinib Dimer Impurity-III
CAT No: VS-I002033
CAS No: N/A
Mol.F.: C50H48N12O4
Mol.Wt.: 881.01
Status: Custom Synthesis
Ibrutinib Dimer-2
CAT No: VS-I002037
CAS No: 2417548-83-3
Mol.F.: C50H48N12O4
Mol.Wt.: 881.01
Status: Custom Synthesis
Ibrutinib Hydroxy Impurity
CAT No: VS-I002015
CAS No: 2031255-24-8
Mol.F.: C25H23N5O3
Mol.Wt.: 441.5
Status: Custom Synthesis
Ibrutinib Impurity 1
CAT No: VS-I002018
CAS No: N/A
Mol.F.: C42H37N11O3
Mol.Wt.: 743.8
Status: Custom Synthesis
Ibrutinib Impurity 11
CAT No: VS-I002028
CAS No: 1288338-96-4
Mol.F.: C25H25ClN6O2
Mol.Wt.: 476.97
Status: Custom Synthesis
Ibrutinib Impurity 14
CAT No: VS-I002031
CAS No: N/A
Mol.F.: C25H24N6O3
Mol.Wt.: 456.5
Status: Custom Synthesis
Ibrutinib Impurity 15
CAT No: VS-I002038
CAS No: 143900-43-0
Mol.F.: C10H19NO3
Mol.Wt.: 201.27
Status: Custom Synthesis
Ibrutinib Impurity 16
CAT No: VS-I002040
CAS No: 89878-72-8
Mol.F.: C18H27ClO2
Mol.Wt.: 310.86
Status: In Stock
Ibrutinib Impurity 17
CAT No: VS-I002041
CAS No: 143900-44-1
Mol.F.: C10H19NO3
Mol.Wt.: 201.3
Status: In Stock
Ibrutinib Impurity 18
CAT No: VS-I002043
CAS No: 2055156-76-6
Mol.F.: C16H10N2O2
Mol.Wt.: 262.3
Status: Custom Synthesis
Ibrutinib Impurity 3
CAT No: VS-I002020
CAS No: 2064175-43-3
Mol.F.: C40H35N6OP
Mol.Wt.: 646.7
Status: Custom Synthesis
Ibrutinib Impurity 4
CAT No: VS-I002021
CAS No: 2064175-44-4
Mol.F.: C43H37N6O2P
Mol.Wt.: 700.8
Status: Custom Synthesis
Ibrutinib Impurity 5
CAT No: VS-I002022
CAS No: N/A
Mol.F.: C47H46N12O3
Mol.Wt.: 827
Status: Custom Synthesis
Ibrutinib Impurity 6
CAT No: VS-I002023
CAS No: N/A
Mol.F.: C38H38N12O3
Mol.Wt.: 710.8
Status: Custom Synthesis
Ibrutinib Impurity 7
CAT No: VS-I002024
CAS No: 2213398-75-3
Mol.F.: C18H15N5O
Mol.Wt.: 317.4
Status: Custom Synthesis
Ibrutinib Impurity 8
CAT No: VS-I002025
CAS No: 936563-92-7
Mol.F.: C25H24N6O2
Mol.Wt.: 440.5
Status: Custom Synthesis
Ibrutinib Impurity D
CAT No: VS-I002030
CAS No: 2052279-48-6
Mol.F.: C28H28N6O4
Mol.Wt.: 512.6
Status: In Stock
Ibrutinib Impurity D
CAT No: VS-I002036
CAS No: 1839099-22-7
Mol.F.: C25H26N6O2
Mol.Wt.: 442.5
Status: Custom Synthesis
Ibrutinib impurity F
CAT No: VS-I002042
CAS No: 79-10-7
Mol.F.: C3H4O2
Mol.Wt.: 72.06
Status: Custom Synthesis
Ibrutinib Methoxy Impurity
CAT No: VS-I002016
CAS No: 2031255-26-0
Mol.F.: C26H28N6O3
Mol.Wt.: 472.5
Status: In Stock
Ibrutinib N1-Oxide
CAT No: VS-I002001
CAS No: 2437254-47-0
Mol.F.: C25H24N6O3
Mol.Wt.: 456.5
Status: Custom Synthesis
Ibrutinib Di-Piperidine Impurity
CAT No: VS-I002034
CAS No: N/A
Mol.F.: C50H48N12O4
Mol.Wt.: 881.0
Status: Custom Synthesis
Ibrutinib-S-isomer
CAT No: VS-I002009
CAS No: 936563-97-2
Mol.F.: C25H24N6O2
Mol.Wt.: 440.5
Status: Custom Synthesis
N1-(2-Carboxyethyl) Ibrutinib
CAT No: VS-I002003
CAS No: N/A
Mol.F.: C28H28N6O4
Mol.Wt.: 512.6
Status: Custom Synthesis
N6-(2-Carboxyethyl) Ibrutinib
CAT No: VS-I002004
CAS No: N/A
Mol.F.: C28H28N6O4
Mol.Wt.: 512.6
Status: Custom Synthesis
N6-Acryloyl Ibrutinib
CAT No: VS-I002002
CAS No: 2031255-27-1
Mol.F.: C28H26N6O3
Mol.Wt.: 494.5
Status: In Stock
Namino-{3-[(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl]-propionyl} Ibrutinib
CAT No: VS-I002013
CAS No: N/A
Mol.F.: C50H48N12O4
Mol.Wt.: 881
Status: Custom Synthesis
N-Desacryloyl N-(3-Acryloyl-propanoyl) Ibrutinib
CAT No: VS-I002005
CAS No: 2244619-11-0
Mol.F.: C28H28N6O4
Mol.Wt.: 512.6
Status: Custom Synthesis
N-Nitroso Ibrutinib Impurity 1
CAT No: VS-I002044
CAS No: 2380680-64-6
Mol.F.: C5H10N2O2
Mol.Wt.: 130.1
Status: Custom Synthesis
N-Nitroso Ibrutinib Impurity 2
CAT No: VS-I002039
CAS No: NA
Mol.F.: C22H21N7O2
Mol.Wt.: 415.5
Status: In Stock
N-Nitroso Ibrutinib Impurity 3
CAT No: VS-I002045
CAS No: 55556-85-9
Mol.F.: C5H10N2O2
Mol.Wt.: 130.15
Status: Custom Synthesis
rac-N-Desacryloyl N-Propionyl Ibrutinib
CAT No: VS-I002006
CAS No: N/A
Mol.F.: C25H26N6O2
Mol.Wt.: 442.5
Status: Custom Synthesis
Ιbrutinib Amine impurity
CAT No: VS-I002011
CAS No: 1022150-12-4
Mol.F.: C22H22N6O
Mol.Wt.: 386.5
Status: Custom Synthesis
Ιbrutinib Pyrimidin impurity
CAT No: VS-I002010
CAS No: 330786-24-8
Mol.F.: C17H13N5O
Mol.Wt.: 303.3
Status: Custom Synthesis
